Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
New York Medical College
University College, London